Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients
NCT00229749
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
80
Enrollment
INDUSTRY
Sponsor class
Stopped
Limited viral load reduction in HCV subjects
Conditions
Hepatitis C
Interventions
DRUG:
AVI-4065 Injection
Sponsor
Sarepta Therapeutics, Inc.